RII retinamide retinoid: SPTA began Phase I testing of the oral agent in 28 patients with refractory anemia.

Sparta Pharmaceuticals Inc. (SPTA), Horsham, Penn. Product: RII retinamide retinoid Indication: Myelodysplastic syndromes Status: SPTA began Phase I testing of the oral agent, a derivative of vitamin ...